Imagen de Portada

Establishing the China–UK Cancer Prevention and Control Alliance

Guardado en:
Publicado en:Lancet Oncology vol. 26, no. 9 (Sep 2025), p. 1132-1135
Autor principal: Ma, Jun
Otros Autores: Kerr, David, Shi, Yuankai, Swanton, Charles, Mok, Tony, Fitzgerald, Rebecca, Xu, Rui-Hua, Cowan, Richard, Lin, Rong, Lawler, Mark, Teng, Gao-Jun, Eisen, Tim, Li, Molly, Kyrgiou, Maria, Ko, Fanny Wai San, Middleton, Mark, Xu, Binghe, Aboyage, Eric, Xiao, Dan, Wu, Yi-Long, Puroshotham, Arnie, Yang, Li, Fan, Daiming
Publicado:
Elsevier Limited
Materias:
Vertex Pharmaceuticals Inc Cancer Research UK Sanofi-Aventis SA AstraZeneca AbbVie Inc Bristol-Myers Squibb Co Daiichi Sankyo Co Ltd BerGenBio ASA Gilead Sciences Inc Pfizer Inc Regeneron Pharmaceuticals Inc Genentech Inc Amgen Inc Merck Sharp & Dohme Mirati Therapeutics Inc
United Kingdom > UK
China
Clinical trials
Artificial intelligence
Collaboration
Funding
Information systems
Biotechnology
Oncology
Patents
Leadership
Medical research
Disease prevention
Cancer research
Life insurance
Drug development
Pharmacology
Health care
Medical innovations
Councils
Cooperation
Pharmaceuticals
Biomarkers
Stock options
Biopharmaceuticals
Education
Cancer therapies
Acceso en línea:Citation/Abstract
Full Text
Full Text - PDF
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Sea el primero en dejar un comentario!
Primero debe ingresar al sistema